Targeting B-Cell Receptor Signaling in Leukemia and Lymphoma: How and Why?
International Journal of Hematologic Oncology · 2016
DOI: 10.2217/ijh-2016-0003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Hematologic Oncology, 2016. Verfasst von John C Allen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular & Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GE, UK. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
B-lymphocytes are dependent on B-cell receptor (BCR) signaling for the constant maintenance of their physiological function, and in many B-cell malignancies this signaling pathway is prone to aberrant activation. This understanding has led to an ever-increasing interest in the signaling networks activated following ligation of the BCR in both normal and malignant cells, and has been critical in establishing an array of small molecule inhibitors targeting BCR-induced signaling. By dissecting how different malignancies signal through BCR, researchers are contributing to the design of more customized therapeutics which have greater efficacy and lower toxicity than previous therapies. This allows clinicians access to an array of approaches to best treat patients whose malignancies have BCR signaling as a driver of pathogenesis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular & Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GE, UK.
- Redx Oncology Plc, Duncan Building, Royal Liverpool University Hospital, Daulby Street, Liverpool, L69 3GA, UK.
- Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Ashton Street, Liverpool, L69 3GE, UK.
Zitieren
APA
Allen, J. C., Talab, F., & Slupsky, J. R. (2016). Targeting B-Cell Receptor Signaling in Leukemia and Lymphoma: How and Why?. International Journal of Hematologic Oncology. https://doi.org/10.2217/ijh-2016-0003
Vancouver
Allen JC, Talab F, Slupsky JR. Targeting B-Cell Receptor Signaling in Leukemia and Lymphoma: How and Why?. International Journal of Hematologic Oncology. 2016. doi:10.2217/ijh-2016-0003
BibTeX
@article{Allen2016,
author = {Allen, John C and Talab, Fatima and Slupsky, Joseph R},
title = {Targeting B-Cell Receptor Signaling in Leukemia and Lymphoma: How and Why?},
journal = {International Journal of Hematologic Oncology},
year = {2016},
doi = {10.2217/ijh-2016-0003}
}
EUVIMED